Cochrane · systematic review · CD014821
Remote care through telehealth for people with inflammatory bowel disease
Gordon, M, Sinopoulou, V, Lakunina, S, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
19
current version
GRADE rated
14
No studies
5
Included studies
NR
No studies 5 · 26.3%Ungraded 0 · 0%Very low 9 · 47.4%Low 1 · 5.3%Moderate 4 · 21.1%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Web‐based disease monitoring compared to usual care
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity (adults) Web‐based disease monitoring vs usual care | no estimate extracted | 3 studies · 428 participants | Moderate Downgraded: risk of bias |
Flare‐ups/relapse (dichotomous; adults) Web‐based disease monitoring vs usual care | RR 1.09 [0.93, 1.27] | 5 studies · 868 participants | Moderate Downgraded: risk of bias |
Flare‐ups/relapse (continuous; adults) Web‐based disease monitoring vs usual care | no estimate extracted | 1 study · 909 participants | Moderate Downgraded: risk of bias |
Flare‐ups/relapse (dichotomous; children) Web‐based disease monitoring vs usual care | RR 0.99 [0.65, 1.51] | 1 study · 170 participants | Low Downgraded: risk of bias, imprecision |
Quality of life (adults) Web‐based disease monitoring vs usual care | no estimate extracted | 4 studies · 1099 participants | Moderate Downgraded: risk of bias |
Web‐based disease monitoring compared to sham monitoring
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity Web‐based disease monitoring vs sham monitoring | no estimate extracted | NR | No studies |
Flare‐ups/relapse Web‐based disease monitoring vs sham monitoring | no estimate extracted | NR | No studies |
Quality of life (adults) Web‐based disease monitoring vs sham monitoring | no estimate extracted | 2 studies · 447 participants | Very low Downgraded: risk of bias, imprecision |
Web‐based disease monitoring compared to self‐screening
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity (adults) Web‐based disease monitoring vs self‐screening | no estimate extracted | 1 study · 102 participants | Very low Downgraded: risk of bias, imprecision |
Flare‐ups/relapse (dichotomous; adults) Web‐based disease monitoring vs self‐screening | no estimate extracted | 1 study · 102 participants | Very low Downgraded: risk of bias, imprecision |
Quality of life (adults) Web‐based disease monitoring vs self‐screening | no estimate extracted | 1 study · 102 participants | Very low Downgraded: risk of bias, imprecision |
Telephone‐based disease monitoring compared to face‐to‐face monitoring
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity (adults) Telephone‐based disease monitoring vs face‐to‐face monitoring | no estimate extracted | 1 study · 60 participants | Very low Downgraded: risk of bias, imprecision |
Flare‐ups/relapse (dichotomous; adults) Telephone‐based disease monitoring vs face‐to‐face monitoring | RR 1.17 [0.47, 2.89] | 1 study · 42 participants | Very low Downgraded: risk of bias, imprecision |
Flare‐ups/relapse (dichotomous; children) Telephone‐based disease monitoring vs face‐to‐face monitoring | RR 0.24 [0.03, 2.05] | 1 study · 86 participants | Very low Downgraded: risk of bias, imprecision |
Quality of life (adults) Telephone‐based disease monitoring vs face‐to‐face monitoring | no estimate extracted | 2 studies · 123 participants | Very low Downgraded: risk of bias, imprecision |
Quality of life (children) Telephone‐based disease monitoring vs face‐to‐face monitoring | no estimate extracted | 1 study · 86 participants | Very low Downgraded: risk of bias, imprecision |
Cognitive behavioural therapy manual and telephone support compared to usual care
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity Cognitive behavioural therapy manual and telephone support vs usual care | no estimate extracted | NR | No studies |
Flare‐ups/relapse Cognitive behavioural therapy manual and telephone support vs usual care | no estimate extracted | NR | No studies |
Quality of life Cognitive behavioural therapy manual and telephone support vs usual care | no estimate extracted | NR | No studies |